Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the early antiviral activity (complete early virologic response rate; cEVR) of GS-9190 versus placebo, in combination with peginterferon alfa 2a (PEG) and ribavirin (RIBA), following 12 weeks of therapy
Critère d'inclusion
- Genotype-1 Chronic Hepatitis C Virus (HCV) Infection